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Photodynamic therapy (PDT) may result in either apoptotic or
necrotic cell death (Noodt et al, 1999). Many stimuli may trigger
apoptosis: DNA damage, tumour necrosis factor, radiation, re-
active oxygen species and elevated intracellular calcium levels.
These stimuli interact with mitochondria, which are thought to be
key regulators of apoptosis (Susin et al, 1998), by activation of the
caspase cascade. Photodynamic therapy may interact with many of
these pathways but it is unclear which is responsible for triggering
apoptosis following PDT. The type of response may vary
according to the cell type, the physical properties and intracellular
localization of the sensitizer (Noodt et al, 1999) and the PDT dose
(Kessel et al, 1995). The effect of PDT dose may reflect the fact
that at low doses the cellular machinery for apoptosis is activated
whereas at higher doses, the apoptotic machinery is itself
damaged. The effect of cell type may depend on the genetics of the
cell, as neoplastic cells often have mutations affecting the apop-
totic machinery. 
MATERIALS AND METHODS 
Cell lines 
MCF 7, Human Mammary Carcinoma (ECACC, European collec-
tion of Animal Cell Cultures, Porton Down, UK). This cell line has
a wild-type p53 gene (Sharma and Srikant, 1998), but a mutation
in the caspase 3 gene (Janicke et al, 1998). 
T47D, Human Mammary Carcinoma (ECACC). This cell line
contains a mutated p53 gene (Bonsing et al, 1997). 
HT1197, Human Bladder Carcinoma (ECACC). This cell line
contains a mutated p53 gene (Cooper et al, 1994). 
WRC, Walker Rat Carcinoma. This cell line contains a wild-
type p53 gene (Tang et al, 1996). 
MVECs, Human Microvascular Endothelial Cells, derived
from human adipose tissue, by the method of Hewitt and Murray
(1993). 
Cell culture techniques 
All of the cell types studied were cultured in their optimal media
and maintained using standard tissue culture techniques. 
Cell death assay: dual staining for apoptosis and
necrosis 
The assay is based on the concurrent use of 2 fluorescent DNA
stains, propidium iodide and Hoechst 33342. Propidium iodide
(PI) stains the nuclei of necrotic cells red (Crissman, 1995).
Hoechst 33342 stains viable and apoptotic nuclei green (Crissman,
1995). Apoptotic and viable cells are discriminated by nuclear
morphology. Cells were plated into 96-well plates and treated with
ALA-PDT at light doses previously calculated to kill 50 or 90% of
cells (LD50 or LD90 light dose). 1 mM ALA was added to the cells
for 4 hours and the cells exposed to violet light (350 to 450 nm,
86.5 mW.cm–2), at light doses varying between 0.5 J.cm–2 and 25
J.cm–2. Controls for light alone, ALA alone and no light/no ALA
were also studied. After 30 minutes, 2, 8 and 24 hours, the cells
were assayed for viability and type of death response by staining
with PI and Hoechst 33342. The total number of necrotic, viable
and apoptotic nuclei were counted per high power field per well. 9
repeats were performed. 
The presence of apoptotic cells was confirmed by TUNEL
labelling (Terminal deoxynucloetidyl transferase-mediated deoxy
Uridine triphophate Nick End Labelling; Gavrieli et al, 1992).
Following PDT, the cells were fixed in paraformaldehyde,
permeabilized in ethanol and treated with the terminal deoxynu-
cleotidyl transferase enzyme (TdT), which catalyses the binding of
fluorescent deoxyuridine triphosphate (fluorescein isothiocyanate,
FITC-dUTP), to the ends of the DNA strand breaks. The fluores-
cein label was then detected by fluorescence microscopy. 
RESULTS 
The light doses required to cause 50 and 90% cell death respec-
tively varied with cell line: HT1197: 0.5 and 3, MCF-7: 4 and 8,
T47D: 1.5 and 4, WRC: 2 and 5 J.cm–2. For MVEC an LD50 light
dose only was studied, and was found to be 25 J.cm–2. At the LD90
light dose for MVECs, some toxicity occurred in the light only
control and therefore this light dose was not studied further. In all
other experiments, no significant toxicity was noted with either
light alone or ALA alone. 
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HT 1197 cells, LD50 and LD90 doses 
Following a LD50 light dose, this cell line died predominantly by
apoptosis, occurring maximally 8 hours after treatment, but
apparent by 30 minutes. Following an LD90 light dose, cell death
was predominantly by necrosis (Table 1). 
MCF-7, LD50 and LD90 doses 
Following both a LD50 and a LD90 light dose, necrotic cell death
only was apparent by 30 minutes and increased to a peak at 24
hours (Table 1). 
T47D, LD50 and LD90 doses 
Following a LD50and a LD90light dose necrotic cell death was apparent
by 30 minutes and increased progressively over the study period to a
peak at 8 hours, followed by a slight decrease at 24 hours (Table 1). 
WRC, LD50 and LD90 doses 
This cell line responded to LD50 PDT predominantly by necrosis
but at 24 hours apoptotic cells appeared. 
Following an LD90 dose this cell line responded to PDT
predominantly by necrosis. Unlike at the LD50 dose, no significant
apoptosis was noted (Table 1). 
MVECs, LD50 dose 
MVECs responded to PDT predominantly by apoptosis, of slower
onset than with HT1197 cells (Table 1). 
TUNEL staining 
Following PDT, only HT1197 cells, MVECs and WRC cells
demonstrated apoptosis. This was confirmed by TUNEL staining.
MCF-7 and T47D cells did not stain. 
DISCUSSION 
Photodynamic therapy causes cell death by apoptosis and necrosis,
depending on the type of cell and the PDT dose. 
The time course of the apoptotic response varies between cell
lines, suggesting that more than one apoptotic pathway may be
involved. The p53 gene is probably not a key mediator of PDT-
induced apoptosis as a p53 mutant cell line (HT1197), died
predominantly by apoptosis. 
The PDT light dose dependency observed in this study for
HT1197 and WRC cells concurs with other studies, demonstrating
apoptosis at low doses which is overwhelmed at higher doses
(Kessel et al, 1995). 
The MCF-7 cell line did not respond to LD50/90 PDT by apop-
tosis dying by necrosis only possibly because these cells contain 
a mutated form of caspase 3 (Janicke et al, 1998) an important
downstream effector of apoptosis. 
Mutations in the genes controlling apoptosis, such as bcl-2 and
p53, are common in malignancies. There is limited research 
investigating the effect of such mutations on PDT-sensitivity.
Since a number of pathways exist whereby PDT can trigger 
apoptosis, this suggests that complete resistance to PDT would be
uncommon. Even in cells where there is failure of one of the steps
in the final common pathway for apoptosis, namely one of the
downstream caspases (such as is the case with the MCF-7 cell 
line; Janicke et al, 1998), the cells will respond by necrosis. This
redundancy of death pathways suggests that treatment failures
with PDT should be rare, provided the appropriate dose is
administered. 
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Table 1 Table showing type of cell death response after LD50 and LD90 photodynamic therapy for a range of cell types 
Percentage of cell death by cell type and PDT dose intensity. 
Time after PDT
HT1197 HT1197 MCF-7 MCF-7 T47D T47D WRC WRC MVEC 
LD50 LD90 LD50 LD90 LD50 LD90 LD50 LD90 LD50
Necrosis 
0.5 hours 6.7 77.7 12.7 53.2 24.9 75.9 8 30.4 0.9 
[1.8] [7.2] [2.17] [7.6] [8.3] [6.6] [2.4] [8.06] [0.5] 
2 hours 10.9 64.3 18.9 61.1 51.1 70.1 17.6 75.8 3.8 
[3.0] [11.4] [4.7] [5.9] [9.7] [8.9] [3.9] [7.2] [1.2] 
8 hours 7.5 52.9 25 82.1 57.5 86.7 27.3 64.7 5.7 
[2.4] [12.0] [4.4] [7.4] [9.4] [8.2] [6.9] [11.5] [1.2] 
24 hours 14.5 73.4 31 87.5 51.4 75.7 43.3 87.5 11.2 
[7.9] [7.5] [4.8] [5.4] [6.3] [12.1] [6.0] [5.09] [1.2] 
Apoptosis 
0.5 hours 8.7 1.1 0 0 0 0 0 0 1.6 
[2.8] [0.5] [0.27] 
2 hours 27.3 28.4 0 0 0 0 0 0 5.1 
[8.2] [10.5] [0.8] 
8 hours 55 25.8 0 0 0 0 0.5 0  11.1 
[6.6] [8.3] [0.2] [1.13] 
24 hours 10.5 4.4 0 0 0 0 3.0 0 30.1 
[3.5] [1.8] [0.37] [2.2] 
Data shown are means plus standard errors [ ]. Necrotic cells were identified by nuclear staining with propidium iodide with normal nuclear morphology. Viable
cells and apoptotic cells were identified by staining with Hoechst 33342, and differentiated by nuclear morphology. 1386 L Wyld et al 
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